Abstract
Canada and France do not have a lot of sunshine but skin cancer is still the most common tumor. The majority of the population is white. The pattern of care for skin cancers is similar to the delivery of care for other cancers. No extra resources are allocated to skin cancer. The general practitioners are the first care providers for skin cancers. Excision or biopsy of the skin lesion establishes the diagnosis. If residual disease is present, further treatments are provided by general practitioners, dermatologists, general or plastic surgeons and radiation oncologists. If adjuvant or definitive treatments are required, patients are referred to cancer services to consider radiotherapy, chemotherapy, targeted therapy or immunotherapy. Both Canada and France have waiting lists for referrals.
Keywords: Pattern of care, rare tumors, registry, skin tumor, treatment.
Current Cancer Therapy Reviews
Title:Pattern of Care for Skin Cancers - Canada and France
Volume: 12 Issue: 2
Author(s): Khanh Vu, Patricia Tai, Avi Assouline and Claude Krzisch
Affiliation:
Keywords: Pattern of care, rare tumors, registry, skin tumor, treatment.
Abstract: Canada and France do not have a lot of sunshine but skin cancer is still the most common tumor. The majority of the population is white. The pattern of care for skin cancers is similar to the delivery of care for other cancers. No extra resources are allocated to skin cancer. The general practitioners are the first care providers for skin cancers. Excision or biopsy of the skin lesion establishes the diagnosis. If residual disease is present, further treatments are provided by general practitioners, dermatologists, general or plastic surgeons and radiation oncologists. If adjuvant or definitive treatments are required, patients are referred to cancer services to consider radiotherapy, chemotherapy, targeted therapy or immunotherapy. Both Canada and France have waiting lists for referrals.
Export Options
About this article
Cite this article as:
Vu Khanh, Tai Patricia, Assouline Avi and Krzisch Claude, Pattern of Care for Skin Cancers - Canada and France, Current Cancer Therapy Reviews 2016; 12 (2) . https://dx.doi.org/10.2174/1573394712666160725155135
DOI https://dx.doi.org/10.2174/1573394712666160725155135 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
HIV-2 Infection and Chemokine Receptors Usage - Clues to Reduced Virulence of HIV-2
Current HIV Research Advances on Magnetic Nanocarriers Based on Natural Polymers
Current Pharmaceutical Design Molecular Imaging of Matrix Metalloproteinases In Vivo Using Small Molecule Inhibitors for SPECT and PET
Current Medicinal Chemistry Magnetic Field-Assisted Gene Delivery: Achievements and Therapeutic Potential
Current Gene Therapy Current Status of Anti-HIV Agents
Current Medicinal Chemistry - Anti-Infective Agents Metalloproteinases Suppression Driven by the Curcumin Analog DM-1 Modulates Invasion in BRAF-Resistant Melanomas
Anti-Cancer Agents in Medicinal Chemistry Nerve Growth Factor Receptors and Signaling in Breast Cancer
Current Cancer Drug Targets Computational Studies of HIV-1 Integrase and its Inhibitors
Current Computer-Aided Drug Design New Perspectives for Melanoma Immunotherapy: Role of IL-12
Current Molecular Medicine Genetically Modified Cellular Vaccines for Therapy of Human Papilloma Virus Type 16 (HPV 16)-Associated Tumours
Current Cancer Drug Targets The Role of Epigenetics in Drug Resistance in Cancer
Epigenetic Diagnosis & Therapy (Discontinued) Unified Multi-target Approach for the Rational in silico Design of Anti-bladder Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Thalidomide Analogues as Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Transient Receptor Potential Channels and Dermatological Disorders
Current Topics in Medicinal Chemistry Autophagy as a Molecular Target of Flavonoids Underlying their Protective Effects in Human Disease
Current Medicinal Chemistry Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells
Current Cancer Therapy Reviews Evidence of PKC Binding and Translocation to Explain the Anticancer Mechanism of Chlorogenic Acid in Breast Cancer Cells
Current Molecular Medicine Doxorubicin vs. ladirubicin: methods for improving osteosarcoma treatment
Mini-Reviews in Medicinal Chemistry Cancer Control by Phytochemicals
Current Pharmaceutical Design Irreversible Inhibition of Serine Proteases – Design and In Vivo Activity of Diaryl α-Aminophosphonate Derivatives
Current Medicinal Chemistry